Edwards Lifesciences (EW) Other Non Operating Income (2015 - 2026)

Edwards Lifesciences has reported Other Non Operating Income for 12 years, with the latest figure at $71.5 million in Q1 2026.

• For the quarter ending Q1 2026, Other Non Operating Income rose 2650.0% year-over-year to $71.5 million; the trailing twelve-month figure through Mar 2026 stood at $76.1 million (up 15.65% YoY), and the FY2025 full-year result was $7.2 million, down 89.55% from the prior year.
• Other Non Operating Income for Q1 2026 stood at $71.5 million, up from $3.2 million in the prior quarter.
• The five-year high for Other Non Operating Income was $71.5 million in Q1 2026, with the low at -$3.3 million in Q1 2022.
• Average Other Non Operating Income over 5 years is $9.8 million, with a median of $3.2 million recorded in 2025.
• Year-over-year, Other Non Operating Income slumped 242.86% in 2022 and jumped 2650.0% in 2026.
• Tracing EW's Other Non Operating Income over 5 years: stood at $5.8 million in 2022, then tumbled by 37.93% to $3.6 million in 2023, then surged by 825.0% to $33.3 million in 2024, then slumped by 90.39% to $3.2 million in 2025, then soared by 2134.38% to $71.5 million in 2026.
• The last three Other Non Operating Income figures came in at $71.5 million (Q1 2026), $3.2 million (Q4 2025), and $2.7 million (Q3 2025), per Business Quant data.

Peer Comparison